tci Medicare Compliance & Reimbursement - 2004 Issue 30
Enforcement Watch: How To Shrug Off An Anti-Kickback Investigation
Subscribe or sign in to view the full article.
Article Overview
This enforcement-focused article discusses a high-profile federal investigation involving a pharmaceutical manufacturer, allegations tied to sales and marketing conduct, and subsequent court developments affecting defendants and a related plea. It is relevant to compliance, health care fraud, pharmaceutical sales oversight, and legal/regulatory audiences monitoring anti-kickback enforcement trends. The article also highlights changing anti-kickback law during the period, prosecution challenges, and the possible impact on future government investigations.
Why This Topic Matters
It helps readers understand how anti-kickback enforcement actions can unfold in the pharmaceutical industry and why court rulings or plea developments may influence compliance risk, defense strategy, and future investigations.
What You Will Learn
- The general scope of a pharmaceutical anti-kickback investigation
- How court outcomes can affect related enforcement actions
- Why changing health care fraud and anti-kickback law matters to compliance efforts
- What this case suggests about government scrutiny of drug marketing practices
Who Should Read This
- Health care compliance professionals
- Medical billing and coding professionals
- Pharmaceutical industry compliance teams
- Health care attorneys
- Fraud and abuse investigators
Subscribe or sign in to view the full article.
Thank you for choosing Find-A-Code, please Sign In to remove ads.


Quick, Current, Complete - www.findacode.com